143 related articles for article (PubMed ID: 15539837)
1. Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma.
Bircan S; Candir O; Serel TA
Urol Int; 2004; 73(3):201-8. PubMed ID: 15539837
[TBL] [Abstract][Full Text] [Related]
2. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
Yin H; Leong AS
Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
[TBL] [Abstract][Full Text] [Related]
3. Urothelial neoplasia of the urinary bladder--comparison of interobserver variability for WHO Classification 1972 with WHO/ISUP Consensus Classification 1998.
Mamoon N; Iqbal MA; Jamal S; Luqman M
J Ayub Med Coll Abbottabad; 2006; 18(2):4-8. PubMed ID: 16977804
[TBL] [Abstract][Full Text] [Related]
4. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
Curry JL; Wojcik EM
Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases.
Gonul II; Poyraz A; Unsal C; Acar C; Alkibay T
Urol Int; 2007; 78(4):338-44. PubMed ID: 17495493
[TBL] [Abstract][Full Text] [Related]
6. The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems.
Busch C; Algaba F
Virchows Arch; 2002 Aug; 441(2):105-8. PubMed ID: 12189498
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
[TBL] [Abstract][Full Text] [Related]
9. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia.
Desai S; Lim SD; Jimenez RE; Chun T; Keane TE; McKenney JK; Zavala-Pompa A; Cohen C; Young RH; Amin MB
Mod Pathol; 2000 Dec; 13(12):1315-23. PubMed ID: 11144928
[TBL] [Abstract][Full Text] [Related]
10. Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts.
Jones TD; Cheng L
J Urol; 2006 Jun; 175(6):1995-2003. PubMed ID: 16697785
[TBL] [Abstract][Full Text] [Related]
11. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.
Campbell PA; Conrad RJ; Campbell CM; Nicol DL; MacTaggart P
BJU Int; 2004 Jun; 93(9):1228-31. PubMed ID: 15180612
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system.
Miyamoto H; Miller JS; Fajardo DA; Lee TK; Netto GJ; Epstein JI
Pathol Int; 2010 Jan; 60(1):1-8. PubMed ID: 20055945
[TBL] [Abstract][Full Text] [Related]
13. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
Whisnant RE; Bastacky SI; Ohori NP
Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer: clinical and pathological profile.
Lopez-Beltran A
Scand J Urol Nephrol Suppl; 2008 Sep; (218):95-109. PubMed ID: 18815924
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma.
Cao D; Vollmer RT; Luly J; Jain S; Roytman TM; Ferris CW; Hudson MA
Urology; 2010 Sep; 76(3):593-9. PubMed ID: 20381131
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of p53 nuclear accumulation in low- and high-grade (WHO/ISUP classification) transitional papillary carcinomas of the bladder for tumor recurrence and progression.
Vardar E; Gunlusoy B; Minareci S; Postaci H; Ayder AR
Urol Int; 2006; 77(1):27-33. PubMed ID: 16825812
[TBL] [Abstract][Full Text] [Related]
17. CD10 expression in urothelial bladder carcinomas: a pilot study.
Bircan S; Candir O; Kapucuoglu N; Serel TA; Ciris M; Karahan N
Urol Int; 2006; 77(2):107-13. PubMed ID: 16888412
[TBL] [Abstract][Full Text] [Related]
18. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
[TBL] [Abstract][Full Text] [Related]
19. Impact of 2004 ISUP/WHO classification on bladder cancer grading.
Lokeshwar SD; Ruiz-Cordero R; Hupe MC; Jorda M; Soloway MS
World J Urol; 2015 Dec; 33(12):1929-36. PubMed ID: 25833661
[TBL] [Abstract][Full Text] [Related]
20. [New WHO classification of urothelial carcinoma of the urinary bladder].
Helpap B
Verh Dtsch Ges Pathol; 2002; 86():57-66. PubMed ID: 12647352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
